Juan Pablo de Torres Tajes-rekin lankidetzan egindako argitalpenak (23)

2024

  1. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100

  2. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma

    eBioMedicine, Vol. 102

2023

  1. Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 29, Núm. 10, pp. 1100-1108

2022

  1. New or enlarging hiatal hernias after thoracic surgery for early lung cancer

    JTCVS Open, Vol. 10, pp. 415-423

2021

  1. Surgical Outcomes in a Lung Cancer-Screening Program Using Low Dose Computed Tomography

    Archivos de Bronconeumologia, Vol. 57, Núm. 2, pp. 101-106

  2. The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD

    Clinical Imaging, Vol. 78, pp. 136-141

2019

  1. 5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging

    Thorax, Vol. 74, Núm. 4, pp. 371-379

  2. Survival with Parenchymal and Pleural Invasion of Non–Small Cell Lung Cancers Less than 30 mm

    Journal of Thoracic Oncology, Vol. 14, Núm. 5, pp. 890-902

2018

  1. Baseline and annual repeat rounds of screening: implications for optimal regimens of screening

    European Radiology, Vol. 28, Núm. 3, pp. 1085-1094

  2. Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer

    Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483

2017

  1. Telomere length, COPD and emphysema as risk factors for lung cancer

    European Respiratory Journal

2016

  1. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT

    Lung Cancer, Vol. 97, pp. 81-86

  2. Impact of surgery for stage IA non-smallcell lung cancer on patient quality of life

    Journal of Community and Supportive Oncology, Vol. 14, Núm. 1, pp. 37-44

2015

  1. Improving selection criteria for lung cancer screening: The potential role of emphysema

    American Journal of Respiratory and Critical Care Medicine, Vol. 191, Núm. 8, pp. 924-931

  2. Lung Cancer Screening: Fourteen Year Experience of the Pamplona Early Detection Program (P-IELCAP)

    Archivos de Bronconeumologia, Vol. 51, Núm. 4, pp. 169-176

2013

  1. Investigation of complement activation product C4d as a diagnostic and prognostic biomarker for lung cancer

    Journal of the National Cancer Institute, Vol. 105, Núm. 18, pp. 1385-1393

  2. Smokers with CT Detected Emphysema and No Airway Obstruction Have Decreased Plasma Levels of EGF, IL-15, IL-8 and IL-1ra

    PLoS ONE, Vol. 8, Núm. 4

2011

  1. Evaluation of micro-CT for emphysema assessment in mice: Comparison with non-radiological techniques

    European Radiology, Vol. 21, Núm. 5, pp. 954-962

  2. FDG uptake and the diagnostic yield of transbronchial needle aspiration

    Journal of Bronchology and Interventional Pulmonology, Vol. 18, Núm. 1, pp. 7-14

  3. Robust, Standardized Quantification of Pulmonary Emphysema in Low Dose CT Exams

    Academic Radiology, Vol. 18, Núm. 11, pp. 1382-1390